After reading this article, you should be able to: Understand the mechanism of action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) analogues
Ellerby LM, Ellerby HM, Park SM, Holleran AL, Murphy AN, Fiskum G et al
Multiple mechanisms likely contribute: Weight loss: Reduces cardiac workload, improves blood pressure, and improves lipid profiles
Risks associated with these compounded forms include contamination, dosing inconsistencies, incorrect formulations, and potentially serious adverse effects due to unvalidated manufacturing processes
Helping your body convert food to fuel, it is a perfect booster following strenuous exercise, a super-demanding long week, or during your menstrual cycle
That raises the prospect, she said, that patients will stop taking the drugs and regain weight, which will lead to poor clinical outcomes. Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments